Trials / Completed
CompletedNCT06104293
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Alyatec · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the optimal concentration of grass pollen allergens inducing rhinoconjunctivitis in subjects allergic to grass pollen in ALYATEC allergen exposure chamber. Four concentrations of grass pollen allergen (Phl p 5) are tested during 3-hour exposures: 0, 30, 60 and 90 ng/m3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Grass Pollen Allergen Exposure | After the screening visit, subjects are randomized into 3 groups presenting a sequence of allergen concentrations with randomly defined concentrations of Ph l p 5 (0, 30, 60 and 90 ng/m3). Each participant undergo four different 3-hour exposure sessions to grass pollen allergen corresponding to the four different allergen concentrations. |
Timeline
- Start date
- 2022-11-16
- Primary completion
- 2023-02-07
- Completion
- 2023-04-06
- First posted
- 2023-10-27
- Last updated
- 2023-11-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06104293. Inclusion in this directory is not an endorsement.